Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PSP: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Gene Symbol | PSP |
| Full Name | Persephin |
| Chromosome | 19q13.33 |
| Protein Family | GDNF family |
| Function | Persephin mediates its effects through specific receptor interactions: |
| Pathways | Differentiation |
| GeneCards | PSP |
| Human Protein Atlas | PSP |
| SNR (Signal-to-Noise Ratio) | FA maps should have SNR > 20 |
| Motion correction | Maximum displacement < 2mm between volumes |
| Eddy current correction | Proper preprocessing is essential |
| Artifact assessment | Check for slice dropout, Gibbs ringing |
| FA | Reduced in cerebral peduncles |
| MD | Elevated in PSP |
| RD | Elevated (reflects demyelination) |
| Associated Diseases | ALS, Aging, Alzheimer, Alzheimer's disease, Dementia |
| Interactions | VPS29, MAPT, GAL, MTOR, TAU, NLGN1 |
| KG Connections | 292 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
PSP["PSP"] -->|"associated"| Alzheimer["Alzheimer"]
style Alzheimer fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
PSP["PSP"] -->|"associated"| Als["Als"]
style Als fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
PSP["PSP"] -->|"associated"| Alzheimer_s_disease["Alzheimer's disease"]
style Alzheimer_s_disease fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
PSP["PSP"] -->|"expressed in"| neurons["neurons"]
style neurons fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
PSP["PSP"] -->|"associated"| frontotemporal_dementia["frontotemporal dementia"]
style frontotemporal_dementia fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
PSP["PSP"] -->|"participates in"| oxidative_stress_response["oxidative stress response"]
style oxidative_stress_response fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#fff
PSP["PSP"] -->|"biomarker for"| Ms["Ms"]
style Ms fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
ALZHEIMER["ALZHEIMER"] -->|"associated"| PSP["PSP"]
style ALZHEIMER fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
DUSP10["DUSP10"] -->|"associated"| PSP["PSP"]
style DUSP10 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
MAP1S["MAP1S"] -->|"associated"| PSP["PSP"]
style MAP1S fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
TAU["TAU"] -->|"activates"| PSP["PSP"]
style TAU fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| PSP["PSP"]
style NEURODEGENERATIVE_DISEASES fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
style PSP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold| Target | Relation | Type | Str |
|---|---|---|---|
| Alzheimer | associated_with | disease | 0.85 |
| Als | associated_with | disease | 0.85 |
| Alzheimer's disease | associated_with | disease | 0.80 |
| neurons | expressed_in | cell_type | 0.80 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.80 |
| SV2A | downregulates | protein | 0.75 |
| tauopathy | targets | disease | 0.75 |
| unfolded protein response | participates_in | pathway | 0.75 |
| STX6 | regulates | gene | 0.70 |
| frontotemporal dementia | associated_with | disease | 0.70 |
| oxidative stress response | participates_in | pathway | 0.70 |
| Parkinson's disease | associated_with | disease | 0.70 |
| Parkinson's disease | regulates | disease | 0.70 |
| tauopathy | associated_with | disease | 0.65 |
| Ms | biomarker_for | disease | 0.65 |
| Dementia | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Tauopathy | activates | disease | 0.65 |
| Sarcopenia | therapeutic_target | disease | 0.65 |
| Aging | treats | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | therapeutic_target | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Senescence | associated_with | disease | 0.65 |
| Traumatic Brain Injury | associated_with | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Als | treats | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Dementia | expressed_in | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | expressed_in | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Ftd | associated_with | disease | 0.65 |
| Frontotemporal Dementia | associated_with | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Tauopathy | therapeutic_target | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Neuropathy | inhibits | disease | 0.65 |
| Alzheimer | stabilizes | disease | 0.65 |
| Als | stabilizes | disease | 0.65 |
| Senescence | therapeutic_target | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ALZHEIMER | associated_with | gene | 0.70 |
| MOBP | regulates | gene | 0.70 |
| DUSP10 | associated_with | gene | 0.60 |
| MAP1S | associated_with | gene | 0.60 |
| TAU | activates | gene | 0.60 |
| PI3K | treats | gene | 0.60 |
| SNCA | therapeutic_target | gene | 0.60 |
| TAU | associated_with | gene | 0.60 |
| CDKN2A | associated_with | gene | 0.60 |
| TAU | expressed_in | gene | 0.60 |
| UBIQUITIN | expressed_in | gene | 0.60 |
| P62 | expressed_in | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| MAPT | activates | gene | 0.60 |
| NLGN1 | inhibits | gene | 0.60 |
| TUBULIN | inhibits | gene | 0.60 |
| PI3K | associated_with | gene | 0.60 |
| PI3K | inhibits | gene | 0.60 |
| TAU | interacts_with | gene | 0.60 |
| PSMB7 | associated_with | gene | 0.60 |
| SLC1A2 | interacts_with | gene | 0.60 |
| MAPT | interacts_with | gene | 0.60 |
| MAPT | regulates | gene | 0.60 |
| MAPT | expressed_in | gene | 0.60 |
| GBA | associated_with | gene | 0.60 |
| GBA | regulates | gene | 0.60 |
| C6 | regulates | gene | 0.60 |
| GPR37 | associated_with | gene | 0.60 |
| NFL | regulates | gene | 0.60 |
| C4A | regulates | gene | 0.60 |
| C4A | interacts_with | gene | 0.60 |
| C4A | causes | gene | 0.60 |
| APOE | regulates | gene | 0.60 |
| DUSP10 | regulates | gene | 0.60 |
| EIF2AK3 | regulates | gene | 0.60 |
| ABCA7 | associated_with | gene | 0.60 |
| ATP13A2 | associated_with | gene | 0.60 |
| BSN | associated_with | gene | 0.60 |
| CYLD | associated_with | gene | 0.60 |
| OPTN | associated_with | gene | 0.60 |
| PSEN2 | associated_with | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | activates | gene | 0.60 |
| MYOD | regulates | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| OXIDATIVE STRESS | inhibits | gene | 0.60 |
| P53 | regulates | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | treats | gene | 0.60 |
| AUTOPHAGY | therapeutic_target | gene | 0.60 |
| NEURODEGENERATION | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.507
neurodegeneration | 2026-04-01 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||